130 related articles for article (PubMed ID: 9766642)
1. Mutational analysis of the transforming growth factor beta receptor type II gene in human ovarian carcinoma.
Lynch MA; Nakashima R; Song H; DeGroff VL; Wang D; Enomoto T; Weghorst CM
Cancer Res; 1998 Oct; 58(19):4227-32. PubMed ID: 9766642
[TBL] [Abstract][Full Text] [Related]
2. Absence of mutations in the analysis of coding sequences of the entire transforming growth factor-beta type II receptor gene in sporadic human breast cancers.
Takenoshita S; Mogi A; Tani M; Osawa H; Sunaga H; Kakegawa H; Yanagita Y; Koida T; Kimura M; Fujita KI; Kato H; Kato R; Nagamachi Y
Oncol Rep; 1998; 5(2):367-71. PubMed ID: 9468559
[TBL] [Abstract][Full Text] [Related]
3. Mutational analysis of the transforming growth factor beta receptor type II gene in hereditary nonpolyposis colorectal cancer and early-onset colorectal cancer patients.
Shin KH; Park YJ; Park JG
Clin Cancer Res; 2000 Feb; 6(2):536-40. PubMed ID: 10690536
[TBL] [Abstract][Full Text] [Related]
4. Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer.
Wang D; Kanuma T; Mizunuma H; Takama F; Ibuki Y; Wake N; Mogi A; Shitara Y; Takenoshita S
Cancer Res; 2000 Aug; 60(16):4507-12. PubMed ID: 10969799
[TBL] [Abstract][Full Text] [Related]
5. Deletion of one adenine base within the polyadenine tract of transforming growth factor-beta receptor type II in human MDA-MB-231 breast cancer cell line.
Park B; Jang JS; Park K
Int J Oncol; 2000 Sep; 17(3):473-8. PubMed ID: 10938386
[TBL] [Abstract][Full Text] [Related]
6. Microsatellite instability and gene mutations in transforming growth factor-beta type II receptor are absent in small bowel carcinoid tumors.
Kidd M; Eick G; Shapiro MD; Camp RL; Mane SM; Modlin IM
Cancer; 2005 Jan; 103(2):229-36. PubMed ID: 15599934
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta receptor type I gene is frequently mutated in ovarian carcinomas.
Chen T; Triplett J; Dehner B; Hurst B; Colligan B; Pemberton J; Graff JR; Carter JH
Cancer Res; 2001 Jun; 61(12):4679-82. PubMed ID: 11406536
[TBL] [Abstract][Full Text] [Related]
8. Mutation analysis of the transforming growth factor-beta type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-beta.
Vincent F; Nagashima M; Takenoshita S; Khan MA; Gemma A; Hagiwara K; Bennett WP
Oncogene; 1997 Jul; 15(1):117-22. PubMed ID: 9233784
[TBL] [Abstract][Full Text] [Related]
9. A dominant negative mutation of transforming growth factor-beta receptor type II gene in microsatellite stable oesophageal carcinoma.
Tanaka S; Mori M; Mafune K; Ohno S; Sugimachi K
Br J Cancer; 2000 May; 82(9):1557-60. PubMed ID: 10789724
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression of TGF-beta cell surface receptors during progression of human oral squamous cell carcinoma.
Paterson IC; Matthews JB; Huntley S; Robinson CM; Fahey M; Parkinson EK; Prime SS
J Pathol; 2001 Apr; 193(4):458-67. PubMed ID: 11276004
[TBL] [Abstract][Full Text] [Related]
11. Accumulated frameshift mutations at coding nucleotide repeats during the progression of gastric carcinoma with microsatellite instability.
Kim JJ; Baek MJ; Kim L; Kim NG; Lee YC; Song SY; Noh SH; Kim H
Lab Invest; 1999 Sep; 79(9):1113-20. PubMed ID: 10496529
[TBL] [Abstract][Full Text] [Related]
12. Lack of frameshift mutations at coding mononucleotide repeats in hepatocellular carcinoma in Japanese patients.
Saeki A; Tamura S; Ito N; Kiso S; Matsuda Y; Yabuuchi I; Kawata S; Matsuzawa Y
Cancer; 2000 Mar; 88(5):1025-9. PubMed ID: 10699890
[TBL] [Abstract][Full Text] [Related]
13. Frequent down-regulation and lack of mutation of the KAI1 metastasis suppressor gene in epithelial ovarian carcinoma.
Liu FS; Dong JT; Chen JT; Hsieh YT; Ho ES; Hung MJ
Gynecol Oncol; 2000 Jul; 78(1):10-5. PubMed ID: 10873402
[TBL] [Abstract][Full Text] [Related]
14. Microsatellite instability, Epstein-Barr virus, mutation of type II transforming growth factor beta receptor and BAX in gastric carcinomas in Hong Kong Chinese.
Leung SY; Yuen ST; Chung LP; Chu KM; Wong MP; Branicki FJ; Ho JC
Br J Cancer; 1999 Feb; 79(3-4):582-8. PubMed ID: 10027334
[TBL] [Abstract][Full Text] [Related]
15. A transforming growth factor-beta receptor-interacting protein frequently mutated in human ovarian cancer.
Ding W; Tang Q; Espina V; Liotta LA; Mauger DT; Mulder KM
Cancer Res; 2005 Aug; 65(15):6526-33. PubMed ID: 16061631
[TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of transforming growth factor-beta receptor type II and Smad3 tumor suppressor genes in prolactinomas.
Ikeda H
Brain Tumor Pathol; 2006 Apr; 23(1):7-12. PubMed ID: 18095113
[TBL] [Abstract][Full Text] [Related]
17. Inhibiting mutations in the transforming growth factor beta type 2 receptor in recurrent human breast cancer.
Lücke CD; Philpott A; Metcalfe JC; Thompson AM; Hughes-Davies L; Kemp PR; Hesketh R
Cancer Res; 2001 Jan; 61(2):482-5. PubMed ID: 11212236
[TBL] [Abstract][Full Text] [Related]
18. Mutation analysis of the transforming growth factor beta type II receptor in sporadic human cancers of the pancreas, liver, and breast.
Vincent F; Hagiwara K; Ke Y; Stoner GD; Demetrick DJ; Bennett WP
Biochem Biophys Res Commun; 1996 Jun; 223(3):561-4. PubMed ID: 8687435
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the TGF beta functional pathway in epithelial ovarian carcinoma.
Francis-Thickpenny KM; Richardson DM; van Ee CC; Love DR; Winship IM; Baguley BC; Chenevix-Trench G; Shelling AN
Br J Cancer; 2001 Sep; 85(5):687-91. PubMed ID: 11531253
[TBL] [Abstract][Full Text] [Related]
20. Abnormalities in expression of genes, mRNA, and proteins of transforming growth factor-beta receptor type I and type II in human pituitary adenomas.
Fujiwara K; Ikeda H; Yoshimoto T
Clin Neuropathol; 1998; 17(1):19-26. PubMed ID: 9496536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
